10.1136/bmjopen-2020-047993 [DOI] [PMC free article] [PubMed] [Google Scholar] Yamamoto K., Amako M., Yamamoto Y., Tsuchihara T., Nukada H., Yoshihara Y., et al
Clinicians considering off-label use must weigh emerging evidence against the lack of formal guidance, ensuring shared decision-making with patients and appropriate monitoring for both physical and psychological outcomes
Different types have been reported according to their differentiation: fibroblastic/myofibroblastic, neural, smooth muscle, ganglionic, rhabdomyoblastic, and neocartilage or chondroid differentiation
The longer-term safety and tolerability profile is not yet known
No personal or family history of medullary thyroid carcinoma or MEN 2 syndrome
For multiple or very large lipomas, TIVA general anaesthesia is available in our on-site theatres